Variability and pathogenicity of hepatitis E virus genotype 3 variants

Area of Science:

• Virology
• Hepatology
• Infectious Diseases

Background:

• Hepatitis E virus (HEV) infection presents with variable clinical outcomes, ranging from asymptomatic to severe hepatitis.
• HEV genotype 3 (HEV-3) variants are classified into clades, suggesting potential genetic influences on pathogenicity.
• Understanding the determinants of HEV clinical variability is crucial for managing the disease.

Purpose of the Study:

• To investigate the association between HEV-3 genetic variability and clinical outcomes in symptomatic versus asymptomatic infections.
• To determine if specific HEV-3 variants correlate with disease severity or liver enzyme levels.

Main Methods:

• Comparative analysis of HEV-3 subgenomic sequences from blood donors (asymptomatic) and hepatitis patients (symptomatic) across the UK, Netherlands, France, and Germany.
• Statistical analysis, including Fisher's exact test, to assess associations between viral variants and patient groups.
• Examination of HEV-3 variants in relation to disease severity and alanine aminotransferase levels in a cohort of Scottish patients.

Main Results:

• No significant association was found between HEV-3 variants and patient groups (symptomatic vs. asymptomatic) in any of the studied countries.
• No correlation was detected between HEV-3 variants and disease severity or alanine aminotransferase levels in patients with clinically apparent HEV infections.
• The genetic variability within HEV-3 does not appear to be a primary driver of clinical presentation or disease severity.

Conclusions:

• The clinical phenotype of HEV-3 infection is likely more influenced by host factors than by viral genetic determinants.
• Further research should focus on host susceptibility and immune responses in understanding HEV pathogenesis.
• Current HEV-3 classification into clades does not predict clinical outcomes in human infections.